232 related articles for article (PubMed ID: 24373695)
21. Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-κB and Nrf2/HO-1 Signalling Pathway Regulation.
Wang Y; Wang B; Du F; Su X; Sun G; Zhou G; Bian X; Liu N
Basic Clin Pharmacol Toxicol; 2015 Sep; 117(3):164-72. PubMed ID: 25625183
[TBL] [Abstract][Full Text] [Related]
22. Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid.
Ran ZH; Chen C; Xiao SD
Biomed Pharmacother; 2008 Mar; 62(3):189-96. PubMed ID: 18325726
[TBL] [Abstract][Full Text] [Related]
23. Shikonin Attenuates Concanavalin A-Induced Acute Liver Injury in Mice via Inhibition of the JNK Pathway.
Liu T; Xia Y; Li J; Li S; Feng J; Wu L; Zhang R; Xu S; Cheng K; Zhou Y; Zhou S; Dai W; Chen K; Wang F; Lu J; Zhou Y; Guo C
Mediators Inflamm; 2016; 2016():2748367. PubMed ID: 27293314
[TBL] [Abstract][Full Text] [Related]
24. Protective mechanism of epigallocatechin-3-gallate against Helicobacter pylori-induced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling.
Lee KM; Yeo M; Choue JS; Jin JH; Park SJ; Cheong JY; Lee KJ; Kim JH; Hahm KB
Helicobacter; 2004 Dec; 9(6):632-42. PubMed ID: 15610077
[TBL] [Abstract][Full Text] [Related]
25. (-)-Epigallocatechin-3-gallate and hydroxytyrosol improved antioxidative and anti-inflammatory responses in bovine mammary epithelial cells.
Basiricò L; Morera P; Dipasquale D; Bernini R; Santi L; Romani A; Lacetera N; Bernabucci U
Animal; 2019 Dec; 13(12):2847-2856. PubMed ID: 31182175
[TBL] [Abstract][Full Text] [Related]
26. Epigallocatechin-3-gallate inhibits TLR4 signaling through the 67-kDa laminin receptor and effectively alleviates acute lung injury induced by H9N2 swine influenza virus.
Xu MJ; Liu BJ; Wang CL; Wang GH; Tian Y; Wang SH; Li J; Li PY; Zhang RH; Wei D; Tian SF; Xu T
Int Immunopharmacol; 2017 Nov; 52():24-33. PubMed ID: 28858723
[TBL] [Abstract][Full Text] [Related]
27. Epigallocatechin-3-gallate inhibits TF and TNF-α expression induced by the anti-β2GPI/β2GPI complex in human THP-1 cells.
Wang T; Zhou H; Xie H; Mu Y; Xu Y; Liu J; Zhang X
Int J Mol Med; 2014 Apr; 33(4):994-1002. PubMed ID: 24481129
[TBL] [Abstract][Full Text] [Related]
28. Green tea polyphenol (-)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway.
Wang D; Wang Y; Wan X; Yang CS; Zhang J
Toxicol Appl Pharmacol; 2015 Feb; 283(1):65-74. PubMed ID: 25585349
[TBL] [Abstract][Full Text] [Related]
29. Prevention of hepatic injury by a traditional Chinese formulation, BJ-JN, in mice treated with Bacille-Calmette-Guérin and lipopolysaccharide.
Zou Y; Yang Y; Li J; Li W; Wu Q
J Ethnopharmacol; 2006 Oct; 107(3):442-8. PubMed ID: 16697540
[TBL] [Abstract][Full Text] [Related]
30. Angelica sinensis polysaccharide attenuates concanavalin A-induced liver injury in mice.
Wang K; Song Z; Wang H; Li Q; Cui Z; Zhang Y
Int Immunopharmacol; 2016 Feb; 31():140-8. PubMed ID: 26741264
[TBL] [Abstract][Full Text] [Related]
31. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of Rabdosia amethystoides (Benth) Hara extract on acute liver injury induced by Concanavalin A in mice through inhibition of TLR4-NF-κB signaling pathway.
Zhai KF; Duan H; Cao WG; Gao GZ; Shan LL; Fang XM; Zhao L
J Pharmacol Sci; 2016 Feb; 130(2):94-100. PubMed ID: 26823124
[TBL] [Abstract][Full Text] [Related]
33. Distinct roles of NF-kappaB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity.
Dambach DM; Durham SK; Laskin JD; Laskin DL
Toxicol Appl Pharmacol; 2006 Mar; 211(2):157-65. PubMed ID: 16081117
[TBL] [Abstract][Full Text] [Related]
34. Quercetin Protects Mice from ConA-Induced Hepatitis by Inhibiting HMGB1-TLR Expression and Down-Regulating the Nuclear Factor Kappa B Pathway.
Li X; Liu HC; Yao QY; Xu BL; Zhang SC; Tu CT
Inflammation; 2016 Feb; 39(1):96-106. PubMed ID: 26267064
[TBL] [Abstract][Full Text] [Related]
35. Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
Fiorini RN; Donovan JL; Rodwell D; Evans Z; Cheng G; May HD; Milliken CE; Markowitz JS; Campbell C; Haines JK; Schmidt MG; Chavin KD
Liver Transpl; 2005 Mar; 11(3):298-308. PubMed ID: 15719408
[TBL] [Abstract][Full Text] [Related]
36. The Protective Effects of Epigallocatechin Gallate Against Distant Organ Damage After Severe Skin Burns--Experimental Study Using a Rat Model of Thermal Trauma.
Hosnuter M; Melikoglu C; Aslan C; Saglam G; Sutcu R
Adv Clin Exp Med; 2015; 24(3):409-17. PubMed ID: 26467128
[TBL] [Abstract][Full Text] [Related]
37. The therapeutic effects of EGCG on vitiligo.
Zhu Y; Wang S; Lin F; Li Q; Xu A
Fitoterapia; 2014 Dec; 99():243-51. PubMed ID: 25128425
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-39 exacerbates concanavalin A-induced liver injury.
Li Y; Gong L; Weng L; Pan X; Liu C; Li M
Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):94-99. PubMed ID: 33412981
[TBL] [Abstract][Full Text] [Related]
39. (-)-Epigallocatechin-3-Gallate Inhibits Arsenic-Induced Inflammation and Apoptosis through Suppression of Oxidative Stress in Mice.
Yu NH; Pei H; Huang YP; Li YF
Cell Physiol Biochem; 2017; 41(5):1788-1800. PubMed ID: 28365685
[TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin-3-gallate ameliorates liver injury secondary to Pseudomonas aeruginosa pneumonia.
Wang Y; Jian S; Li W; Zhao L; Ye G; Shi F; Li L; Zou Y; Song X; Zhao X; Yin Z; Li Y; Tang H
Int Immunopharmacol; 2022 Nov; 112():109239. PubMed ID: 36113316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
